SCHEMBL112298

SCHEMBL112298

O=Cc1cccc2c1Nc1ccccc1S2

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOX1 Q9Y5S8 9/20 0.53
MAPT P10636 6/20 0.53
GAA P10253 5/20 0.53
MEN1 O00255 4/20 0.53
KMT2A Q03164 4/20 0.53
SNCA P37840 3/20 0.53
TDP1 Q9NUW8 3/20 0.53
BCHE P06276 2/20 0.53
ACHE P22303 2/20 0.53
ALOX15 P16050 2/20 0.53
CYP1A2 P05177 1/20 0.53
POLB P06746 1/20 0.53
CYP3A4 P08684 1/20 0.53
ADORA3 P0DMS8 1/20 0.53
ALOX12 P18054 1/20 0.53
MAOA P21397 1/20 0.53
CNR1 P21554 1/20 0.53
PTGS1 P23219 1/20 0.53
SLC6A2 P23975 1/20 0.53
HTR2C P28335 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30537318 1.00 NOX1 (0.53) NOX1MAPTGAAMEN1KMT2A
SCHEMBL28402040 0.83 NOX1 (0.50) NOX1MAPTGAAMEN1KMT2A
SCHEMBL1767892 0.83 NOX1 (0.53) NOX1MAPTGAAMEN1KMT2A
SCHEMBL290727 0.83 NOX1 (0.53) NOX1MAPTGAAMEN1KMT2A
SCHEMBL6005188 0.83 NOX1 (0.53) NOX1MAPTGAAMEN1KMT2A
SCHEMBL11278823 0.79 NOX1 (0.53) NOX1MAPTGAAMEN1KMT2A
SCHEMBL30957952 0.79 NOX1 (0.48) NOX1MAPTGAAMEN1KMT2A
SCHEMBL988099 0.79 NOX1 (0.48) NOX1MAPTGAAMEN1KMT2A
SCHEMBL988100 0.79 NOX1 (0.48) NOX1MAPTGAAMEN1KMT2A
Phenothiazine SCHEMBL28700717 0.78 TRIM24 (0.60) NOX1MAPTGAAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 2162 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117487159-A Covalent organic framework material based on quinoline ring connection and preparation method thereof 安徽大学 2024-02-02 CN claimed
CN-110894191-B Phenothiazinyl conjugated benzylidene ketone photosensitizer as well as preparation method and application thereof 安庆北化大科技园有限公司 2023-06-20 CN claimed
EP-2016044-B1 PENTACYCLINE DERIVATIVES FOR THE TREATMENT OF INFECTIONS HARVARD COLLEGE (US) 2020-06-10 EP claimed
CN-110894191-A Phenothiazinyl conjugated benzylidene ketone photosensitizer and preparation method and application thereof 安庆北化大科技园有限公司 2020-03-20 CN claimed
EP-3323414-A1 INHIBITORS OF NEDD8-ACTIVATING ENZYME Millennium Pharmaceuticals, Inc. (US) 2018-05-23 EP claimed
EP-2550285-B1 TRIOXACARCINS AND USES THEREOF HARVARD COLLEGE (US) 2017-07-19 EP claimed
US-20150376201-A1 CORTISTATIN ANALOGUES AND SYNTHESES THEREOF PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2015-12-31 US claimed
CN-103214409-B The synthesis of tsiklomitsin and analogue thereof PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2015-10-21 CN claimed
CN-102227409-B Pyridine-3-carboxyamide derivative KOWA CO 2014-03-26 CN claimed
CN-102558092-B N-formyl phenothiazine and preparation method thereof UNIV SHAANXI SCIENCE & TECH 2014-01-29 CN claimed
CN-103159698-A N-formyl phenothiazine 1, 3-diaminourea compound and preparation method thereof UNIV SHAANXI SCIENCE & TECH 2013-06-19 CN claimed
JP-4685861-B2 2011-05-18 JP claimed
EP-1749001-B1 3-PIPERIDINYLISOCHROMAN-5-OLS AS DOPAMINE AGONISTS AVENTIS PHARMA INC (US) 2010-03-03 EP claimed
US-20070099955-A1 3-PIPERIDINYLISOCHROMAN-5-OLS AS DOPAMINE AGONISTS AVENTIS PHARMACEUTICALS INC. (US) 2007-05-03 US claimed
EP-1761554-A2 PEPTIDE ANTIBIOTICS AND METHODS FOR MAKING SAME Biosource Pharm, Inc. (US) 2007-03-14 EP claimed
EP-1749001-A1 3-PIPERIDINYLISOCHROMAN-5-OLS AS DOPAMINE AGONISTS Aventis Pharmaceuticals, Inc. (US) 2007-02-07 EP claimed
WO-2006083317-A2 PEPTIDE ANTIBIOTICS AND METHODS FOR MAKING SAME BIOSOURCE PHARM, INC. (US) 2006-08-10 WO claimed
WO-2005111025-A1 3-PIPERIDINYLISOCHROMAN-5-OLS AS DOPAMINE AGONISTS AVENTIS PHARMACEUTICALS INC. (US) 2005-11-24 WO claimed
US-12037355-B2 Triterpene saponin analogues ADJUVANCE TECHNOLOGIES, INC. (US) 2024-07-16 US disclosed
EP-0587088-A1 Derivatives of substituted cyclohexane, their process of preparation and their application with the treatment of diseases HOECHST AKTIENGESELLSCHAFT (DE) 1994-03-16 EP disclosed